JOHN C MARTIN Insider Trading $GILD GILEAD SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN C MARTIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN C MARTIN. JOHN C MARTIN is Chairman and CEO in GILEAD SCIENCES INC ($GILD) and Director in GILEAD SCIENCES INC ($GILD) and Executive Chairman in GILEAD SCIENCES INC ($GILD) and President and CEO in GILEAD SCIENCES INC ($GILD) and Director in Sarepta Therapeutics, Inc. ($SRPT) and Director in Kronos Bio, Inc. ($KRON).
JOHN C MARTIN in GILEAD SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN C MARTIN: Director, Executive Chairman, Chairman and CEO, President and CEO
Holdings: 2,885,507 shares
Current Value: $211,017,127
Latest Transaction: Feb 08 2019
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN C MARTIN in GILEAD SCIENCES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GILD, KRON, SRPT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Payment of Exercise | F | 68.75 | 13,787 | 947,856 | 2,887,225 | 2.9 M to 2.9 M (-0.48 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Grant | A | 0.00 | 15,505 | 0 | 2,901,012 | 2.9 M to 2.9 M (+0.54 %) |
| Feb 08 2019 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Grant | A | 0.00 | 7,745 | 0 | 2,885,507 | 2.9 M to 2.9 M (+0.27 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 0 | |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 72.67 | 200 | 14,533 | 2,877,762 | 2.9 M to 2.9 M (-0.01 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 71.95 | 13,958 | 1,004,275 | 2,877,962 | 2.9 M to 2.9 M (-0.48 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 70.90 | 35,842 | 2,541,370 | 2,891,920 | 2.9 M to 2.9 M (-1.22 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 2,927,762 | 2.9 M to 2.9 M (+1.74 %) |
| Dec 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Gift | G | 0.00 | 140,000 | 0 | 2,877,762 | 3 M to 2.9 M (-4.64 %) |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 50,000 | |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 70.15 | 13,579 | 952,632 | 3,017,762 | 3 M to 3 M (-0.45 %) |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 69.53 | 28,421 | 1,976,135 | 3,031,341 | 3.1 M to 3 M (-0.93 %) |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 68.61 | 8,000 | 548,850 | 3,059,762 | 3.1 M to 3.1 M (-0.26 %) |
| Nov 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Oct 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 100,000 | |
| Oct 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 78.34 | 16,670 | 1,305,853 | 3,017,762 | 3 M to 3 M (-0.55 %) |
| Oct 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 77.90 | 33,330 | 2,596,357 | 3,034,432 | 3.1 M to 3 M (-1.09 %) |
| Oct 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Sep 06 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 150,000 | |
| Sep 06 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 75.00 | 2,624 | 196,790 | 3,017,762 | 3 M to 3 M (-0.09 %) |
| Sep 06 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 74.11 | 47,376 | 3,511,244 | 3,020,386 | 3.1 M to 3 M (-1.54 %) |
| Sep 06 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Aug 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 200,000 | |
| Aug 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 77.85 | 50,000 | 3,892,650 | 3,017,762 | 3.1 M to 3 M (-1.63 %) |
| Aug 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 250,000 | |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 71.36 | 300 | 21,408 | 3,017,762 | 3 M to 3 M (-0.01 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 250,000 | |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 70.80 | 49,700 | 3,518,874 | 3,018,062 | 3.1 M to 3 M (-1.62 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 71.36 | 300 | 21,408 | 3,017,762 | 3 M to 3 M (-0.01 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 70.80 | 49,700 | 3,518,874 | 3,018,062 | 3.1 M to 3 M (-1.62 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Jun 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 300,000 | |
| Jun 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 68.13 | 50,000 | 3,406,495 | 3,017,762 | 3.1 M to 3 M (-1.63 %) |
| Jun 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 2,593 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 350,000 | |
| May 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 72.19 | 50,000 | 3,609,660 | 3,017,762 | 3.1 M to 3 M (-1.63 %) |
| May 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 400,000 | |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 74.98 | 700 | 52,484 | 3,017,762 | 3 M to 3 M (-0.02 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 74.33 | 9,962 | 740,466 | 3,018,462 | 3 M to 3 M (-0.33 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 73.39 | 13,080 | 959,890 | 3,028,424 | 3 M to 3 M (-0.43 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 72.51 | 26,258 | 1,903,965 | 3,041,504 | 3.1 M to 3 M (-0.86 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Mar 13 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | A | 0.00 | 310 | 0 | 310 | |
| Mar 13 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | A | 80.72 | 1,309 | 105,662 | 1,309 | |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 450,000 | |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 79.49 | 6,523 | 518,522 | 3,017,762 | 3 M to 3 M (-0.22 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 78.95 | 26,575 | 2,098,200 | 3,024,285 | 3.1 M to 3 M (-0.87 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 77.84 | 16,902 | 1,315,653 | 3,050,860 | 3.1 M to 3.1 M (-0.55 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Payment of Exercise | F | 80.69 | 19,354 | 1,561,674 | 3,017,762 | 3 M to 3 M (-0.64 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 18,630 | 0 | 3,037,116 | 3 M to 3 M (+0.62 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 21,380 | 0 | 3,018,486 | 3 M to 3 M (+0.71 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 62.35 | 340 | 21,198 | 2,997,106 | 3 M to 3 M (+0.01 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 500,000 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.69 | 30,723 | 2,571,125 | 2,996,766 | 3 M to 3 M (-1.01 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.35 | 19,277 | 1,606,699 | 3,027,489 | 3 M to 3 M (-0.63 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,046,766 | 3 M to 3 M (+1.67 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 550,000 | |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 73.95 | 18,954 | 1,401,614 | 2,996,766 | 3 M to 3 M (-0.63 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 73.60 | 26,941 | 1,982,987 | 3,015,720 | 3 M to 3 M (-0.89 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 72.26 | 4,105 | 296,634 | 3,042,661 | 3 M to 3 M (-0.13 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,046,766 | 3 M to 3 M (+1.67 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 0 | |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 74.35 | 12,500 | 929,409 | 2,996,766 | 3 M to 3 M (-0.42 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.57 | 101 | 7,633 | 3,009,266 | 3 M to 3 M (0.00 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.11 | 60,732 | 4,561,344 | 3,009,367 | 3.1 M to 3 M (-1.98 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,070,099 | 3 M to 3.1 M (+2.45 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 73,333 | |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.60 | 7,477 | 565,295 | 2,996,766 | 3 M to 3 M (-0.25 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.08 | 65,856 | 4,944,403 | 3,004,243 | 3.1 M to 3 M (-2.15 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,070,099 | 3 M to 3.1 M (+2.45 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 146,666 | |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 82.62 | 68,133 | 5,628,855 | 2,996,766 | 3.1 M to 3 M (-2.22 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 81.82 | 5,200 | 425,464 | 3,064,899 | 3.1 M to 3.1 M (-0.17 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,070,099 | 3 M to 3.1 M (+2.45 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 219,999 | |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.43 | 14,995 | 1,251,094 | 2,996,766 | 3 M to 3 M (-0.50 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.03 | 58,338 | 4,843,897 | 3,011,761 | 3.1 M to 3 M (-1.90 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,070,099 | 3 M to 3.1 M (+2.45 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Gift | G | 0.00 | 129,870 | 0 | 2,996,766 | 3.1 M to 3 M (-4.15 %) |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 293,332 | |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.86 | 73,333 | 5,562,777 | 3,126,636 | 3.2 M to 3.1 M (-2.29 %) |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,199,969 | 3.1 M to 3.2 M (+2.35 %) |
| Jul 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 366,665 | |
| Jul 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 71.00 | 73,333 | 5,206,892 | 3,126,636 | 3.2 M to 3.1 M (-2.29 %) |
| Jul 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,199,969 | 3.1 M to 3.2 M (+2.35 %) |
| Jun 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 293,332 | |
| Jun 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 65.24 | 73,333 | 4,784,531 | 3,199,969 | 3.3 M to 3.2 M (-2.24 %) |
| Jun 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,273,302 | 3.2 M to 3.3 M (+2.29 %) |
| May 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 513,331 | |
| May 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 68.31 | 73,333 | 5,009,429 | 3,126,636 | 3.2 M to 3.1 M (-2.29 %) |
| May 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,199,969 | 3.1 M to 3.2 M (+2.35 %) |
| Apr 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 586,664 | |
| Apr 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 67.85 | 10,500 | 712,385 | 3,126,636 | 3.1 M to 3.1 M (-0.33 %) |
| Apr 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 67.07 | 62,833 | 4,213,901 | 3,137,136 | 3.2 M to 3.1 M (-1.96 %) |
| Apr 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,199,969 | 3.1 M to 3.2 M (+2.35 %) |
| Mar 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 659,997 | |
| Mar 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 70.38 | 73,333 | 5,161,206 | 3,126,636 | 3.2 M to 3.1 M (-2.29 %) |
| Mar 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,199,969 | 3.1 M to 3.2 M (+2.35 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | A | 70.31 | 123,210 | 8,662,895 | 123,210 | |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Payment of Exercise | F | 70.31 | 25,271 | 1,776,804 | 3,126,636 | 3.2 M to 3.1 M (-0.80 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 8,572 | 0 | 3,151,907 | 3.1 M to 3.2 M (+0.27 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 11,924 | 0 | 3,143,335 | 3.1 M to 3.1 M (+0.38 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 59.33 | 315 | 18,689 | 3,131,411 | 3.1 M to 3.1 M (+0.01 %) |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 733,330 | |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 72.57 | 73,333 | 5,322,069 | 3,131,096 | 3.2 M to 3.1 M (-2.29 %) |
| Feb 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,204,429 | 3.1 M to 3.2 M (+2.34 %) |
| Jan 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,337 | 1,582,246 | 806,663 | |
| Jan 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 73.84 | 50,760 | 3,748,017 | 3,131,096 | 3.2 M to 3.1 M (-1.60 %) |
| Jan 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 73.04 | 22,577 | 1,648,954 | 3,181,856 | 3.2 M to 3.2 M (-0.70 %) |
| Jan 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,337 | 1,582,246 | 3,204,433 | 3.1 M to 3.2 M (+2.34 %) |
| Dec 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 0 | |
| Dec 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 73.33 | 100,000 | 7,332,870 | 3,131,096 | 3.2 M to 3.1 M (-3.09 %) |
| Dec 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 3,231,096 | 3.1 M to 3.2 M (+3.19 %) |
| Nov 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 100,000 | |
| Nov 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 74.15 | 6,400 | 474,591 | 3,131,096 | 3.1 M to 3.1 M (-0.20 %) |
| Nov 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 73.73 | 93,600 | 6,901,456 | 3,137,496 | 3.2 M to 3.1 M (-2.90 %) |
| Nov 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 3,231,096 | 3.1 M to 3.2 M (+3.19 %) |
| Oct 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 200,000 | |
| Oct 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 78.57 | 500 | 39,283 | 3,131,096 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 77.62 | 99,500 | 7,723,678 | 3,131,596 | 3.2 M to 3.1 M (-3.08 %) |
| Oct 05 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 3,231,096 | 3.1 M to 3.2 M (+3.19 %) |
| Sep 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 300,000 | |
| Sep 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 78.19 | 4,400 | 344,047 | 3,131,096 | 3.1 M to 3.1 M (-0.14 %) |
| Sep 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 77.45 | 95,600 | 7,404,316 | 3,135,496 | 3.2 M to 3.1 M (-2.96 %) |
| Sep 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 3,231,096 | 3.1 M to 3.2 M (+3.19 %) |
| Sep 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Gift | G | 0.00 | 156,714 | 0 | 3,131,096 | 3.3 M to 3.1 M (-4.77 %) |
| Sep 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Gift | G | 0.00 | 731,917 | 0 | 3,287,810 | 4 M to 3.3 M (-18.21 %) |
| Sep 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | J | 0.00 | 731,917 | 0 | 731,917 | 0 to 731.9 K |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 400,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 400,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 400,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.72 | 63,584 | 5,132,558 | 4,019,727 | 4.1 M to 4 M (-1.56 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 80.11 | 36,416 | 2,917,227 | 4,083,311 | 4.1 M to 4.1 M (-0.88 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 500,000 | |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 85.03 | 30,718 | 2,612,093 | 4,019,727 | 4.1 M to 4 M (-0.76 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 84.68 | 64,582 | 5,468,629 | 4,050,445 | 4.1 M to 4.1 M (-1.57 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.36 | 4,700 | 391,801 | 4,115,027 | 4.1 M to 4.1 M (-0.11 %) |